BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 2686529)

  • 1. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
    Lavialle C; Modjtahedi N; Cassingena R; Brison O
    Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
    Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
    Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line.
    Modjtahedi N; Lavialle C; Poupon MF; Landin RM; Cassingena R; Monier R; Brison O
    Cancer Res; 1985 Sep; 45(9):4372-9. PubMed ID: 4028021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
    Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
    Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
    Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
    Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.
    Donzelli M; Bernardi R; Negri C; Prosperi E; Padovan L; Lavialle C; Brison O; Scovassi AI
    Oncogene; 1999 Jan; 18(2):439-48. PubMed ID: 9927200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line.
    Guillaud-Bataille M; Brison O; Danglot G; Lavialle C; Raynal B; Lazar V; Dessen P; Bernheim A
    Cytogenet Genome Res; 2009; 124(1):1-11. PubMed ID: 19372663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
    Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
    Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.
    Brondyk WH; Boeckman FA; Fahl WE
    Oncogene; 1991 Jul; 6(7):1269-76. PubMed ID: 1861869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line.
    Galdemard C; Brison O; Lavialle C
    Oncogene; 1995 Jun; 10(12):2331-42. PubMed ID: 7784081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
    Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA
    Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
    Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
    Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of myc gene amplification in human somatic cell hybrids.
    Iman DS; Shay JW
    Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.
    Zajchowski D; Band V; Pauzie N; Tager A; Stampfer M; Sager R
    Cancer Res; 1988 Dec; 48(24 Pt 1):7041-7. PubMed ID: 3191480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
    Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.
    Bover L; Barrio M; Bravo AI; Slavutsky I; Larripa I; Bolondi A; Ayala M; Mordoh J
    Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):493-504. PubMed ID: 9620446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
    Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
    Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.